PedAM
Pediatric Disease Annotations & Medicines
| Disease | skin disease |
| Phenotype | C1258104|diffuse cutaneous systemic sclerosis |
| Sentences | 2 |
| PubMedID- 20112379 | A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. |
| PubMedID- 26286345 | The placebo-controlled phase-2 fasscinate trial provided tantalizing data indicating that the prolonged use of tocilizumab may slow down lung and skin disease in patients with early diffuse cutaneous systemic sclerosis [6]. |
Page: 1